Maze Therapeutics, Inc.

MAZE · XNAS

CIK 1842295fmd_0PRN2Y3XCV4N3WSPWJHRMWCHNNManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2024 to Sep 30, 2026, 11 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.